Gene Query: TSEN34

Dataset Description Geneva Score
MARS Seq data from human cortical organoids 30.18
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 25.47
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 21.42
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 21.27
Cleavage Factor Im as a key regulator of 3’ UTR length 19.87
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and AXL-/- astrocytes Transcriptomes 18.87
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 17.44
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 16.2
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 15.54
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 15.3
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 14.72
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 14.18
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 14.12
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 14.12
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 14.04
Overexpression of NFIB and YBX1 in MCF-7 cells 14.01
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 13.77
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 13.21
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 12.86
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 12.84
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 12.47
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 12.4
Genome wide expression change by RNF168 knocking down in MCF-7 cells 12.18
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 12.07
Global expression profiles in cardiac progenitor cells generated by ISX-9 11.93
Global mRNA expression profile in cardiac progenitor cells generated by ISX-9 11.93
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 11.89
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 11.79
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 11.77
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 11.58
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 11.53
Transcriptome-wide profiling of poly(A)-tail length, translation efficiency and mRNA stability using TED-seq, mRNA-seq, Ribo-seq and PRO-seq in ER stress conditions 11.23
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 11.2
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 11.2
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 11.11
Poly(A)-ClickSeq resolves CF25-mediated alternative poly-adenylation, HeLa 11.11
The effect of Abl kinases on non-small cell carcinoma global transcriptome 11.01
RNA-seq analysis of A2780 and OVCAR3 human ovarian cancer cell lines after overexpression of collagen type XI alpha 1 (COL11A1) 10.62
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 10.59
Conservative alteration of chromosomal expression pattern across human solid tumor types 10.53
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 10.48
Identifying lincRNA as prognostic biomarker for clear cell renal cell carcinoma 10.44
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 10.34
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 10.27
Gene expression in control and DOCK8 CRISPR KHYG1 NK cells 10.15
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 10.02
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 9.99
RNA-Seq in neutrophils from Antiphospholipid Syndrome 9.96
ARID1A and ARID1B loss in HCT116 cells 9.96
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 9.82
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 9.56
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 9.41
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 9.33
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 9.31
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 9.26
Dysregulated immune system networks in war veterans with PTSD 9.22
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 9.05
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 9.05
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 8.94
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 8.91
RNAseq analysis of the human neutrophil transcriptome, with and without in vitro cytokine stimulation 8.88
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures [RNA-Seq] 8.82
High-resolution liver cancer genomic profiling links etiology, epigenetic and mutation signatures 8.82
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 8.8
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 8.73
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 8.66
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 8.36
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 8.29
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 8.24
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 8.13
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 8.08
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 8.03
Gene expression analysis in U251 and U87 cells transduced with NANEP5 vector. 8.03
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 7.94
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 7.93
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.72
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 7.69
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 7.65
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 7.58
Identification of differentially spliced genes by wild type or S34F mutation of U2AF1 7.56
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.55
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 7.53
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration 7.5
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 7.43
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 7.4
Next-generation sequencing of human dermal fibroblasts transdifferentiated towards the otic lineage 7.39
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 7.39
Gene expression changes caused by KRAS in MCF-10A 7.38
Next Generation Sequencing and m6A sequencing Facilitates Quantitative Analysis of Wild Type and genetic FTO knockdown ccRCC cells Transcriptomes 7.24
MYOD Remodeling of the Genome Architecture during Myogenic Conversion of Somatic Cells 7.21
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 7.18
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 7.16
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 7.13
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 7.12
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 7.06
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 7.06
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 7.02
Identification of transcription start sites for human A549 cell line using ReCappable-seq 6.98
Defective structural RNA processing in relapsing-remitting multiple sclerosis 6.95
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 6.94
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 6.88
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 6.86
Comprehensive comparative analysis of 5’ end RNA sequencing methods 6.86
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 6.77
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability 6.76
Generating Patterned Kidney Organoids for Studying Development and Diseases 6.75
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 6.72
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 6.72
scRNASeq analysis of cycling cardiomyocytes 6.69
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 6.67
hTERT promotes cell adhesion and migration independent of telomerase activity 6.59
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 6.59
Transcriptome analysis of kidney organoids 6.56
Tpl-2 small molecule project 6.54
Tpl-2 and MEK small molecule inhibitors 6.54
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.49
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.49
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.43
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 6.43
Differential gene expression of human melanoma cells [RNA-seq] 6.42
GDF6-induced BMP signaling reawakens a neural crest identity in melanoma to prevent cell death and differentiation 6.42
Single-cell analysis of human kidney organoids 6.39
Involvement of Condensin in Cellular Senescence through Gene Regulation and Compartmental Reorganization 6.32
Intron retention induced by microsatellite expansions as a disease biomarker. 6.3
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 6.29
IL-21/type I interferon interplay regulates neutrophil-dependent innate immune responses to Staphylococcus aureus 6.18
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 6.12
Glioblastoma stem cells infected by ZIKA virus 6.11
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 6.11
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies [RNA-seq data set 2] 6.1
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 6.04
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 5.96
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 5.87
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.84
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 5.82
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 5.81
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 5.76
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 5.75
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 5.75
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 5.71
Gene expression alterations associated with acquired-resistance to the CDK4/6 inhibitor palbociclib [Palbociclib resistance_RNASeq] 5.68
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 5.68
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 5.66
HNF1A deficiency impairs β-cell fate, granule maturation and function 5.64
Transcriptome profiling of Caki2 cells re-expressing Polybromo-1 (PBRM1) 5.63
NRDE2 negatively regulates nuclear exosome functions 5.6
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 5.6
Peptidomimetic blockade of MYB in acute myeloid leukemia 5.6
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 5.55
Expression profile of Lo19S state cells in the presence and absence of bortezomib treatment 5.55
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 5.54
Three-dimensional Oxabicycloheptene sulfonate targets the homologous recombination and repair programs through estrogen receptor α antagonism 5.51
EWSR1 influences alternative splicing through direct and indirect mechanisms 5.48
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 5.47
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 5.46
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 5.44
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 5.43
Re-Wiring 3D Nuclear Architecture by a Single Transcription Factor during Somatic Cell Reprogramming 5.42
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 5.4
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 5.4
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 5.39
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 5.37
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 5.33
PTHrP overexpression in MCF7 cells 5.32
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 5.32
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 5.31
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 5.29
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 5.28
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 5.22
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 5.19
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 5.16
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 5.16
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 5.15
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 5.07
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 5.04
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.01
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.01
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 4.99
Transcriptome analysis of BAP1 knockout and restoration 4.99
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 4.99
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 4.99
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 4.99
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 4.99
Tracking distinct RNA populations using efficient and reversible covalent chemistry 4.99
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.94
Identification of renal resident macrophages across species 4.92
RNAseq Study in CC-671 Treated Cal-51 Cells 4.9
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 4.89
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 4.89
CD73 knockdown effect in pancreatic cancer cell lines 4.87
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 4.86
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 4.85
RNA-seq after siRNA targeting DDX24 applied to iHUVECs cell lines 4.85
DNMT and HDAC inhibitors globally induce cryptic TSSs encoded in long terminal repeats 4.84
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 4.83
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 4.83
MeRIP-seq for heat shock in B-cell lymphoma cells 4.8
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 4.76
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 4.72
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 4.71
Transcriptome analysis reveals malignant and hypoxic signature of glioblastoma 4.7
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 4.68
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 4.68
TOP2B disturbed the quality of human oocytes with advanced maternal age 4.68
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 4.64
Mapping interactions for the TNIP2 hub protein 4.61
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 4.6
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 4.6
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 4.59
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 4.58
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 4.58
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.57
FBXW7 modulates stress response by post-translational modification of HSF1 4.57
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 4.56
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.54
MYOD Gene Expression Regulation during Myogenic Conversion of Fibroblasts 4.51
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 4.5
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 4.47
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 4.41
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 4.4
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 4.39
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 4.38
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 4.38
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.37
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 4.37
Retinoic acid suppresses MYB in adenoid cystic carcinoma 4.37
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 4.36
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.28
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 4.26
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 4.25
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 4.23
RUNX2/CBFB modulates the response to MEK inhibitors through activation of receptor tyrosine kinases in KRAS mutant colorectal cancer 4.13
Profiling of escape kinetics of viruses subjected to RNAi 4.08
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.08
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.08
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 4.07
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 4.07
RNAseq of IL-36 stimulated primary human keratinocytes 4.06
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.04
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.04
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 4.03
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 4.02
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.01
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 3.98
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.98
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 3.96
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.95
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 3.91
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 3.91
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 3.87
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 3.86
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 3.86
SLAM-seq for K562 endogenous mRNA decay 3.85
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 3.85
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 3.84
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 3.83
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 3.83
A comparison of gene expression between lesional and non-lesional derived keratinocytes of Hailey-Hailey disease patients. 3.82
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 3.81
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 3.79
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 3.77
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 3.77
RNA editing in nascent RNA affects pre-mRNA splicing 3.77
Effect of CHKA knockdown on C4-2 cell transcriptome 3.76
Transcriptome Profiling of Influenza A Virus-infected Lung Epithelial (A549) Cells with Lariciresinol-4-β-D-glucopyranoside Treatment 3.76
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 3.76
Analysis of an artificial zinc finger epigenetic modulator: widespread binding but limited regulation 3.75
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 3.72
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 3.72
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 3.7
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 3.7
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 3.7
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance 3.68
MicroRNA-mediated suppression of the TGF-β pathway confers transmissible and reversible CDK4/6 inhibitor resistance (RNA-Seq) 3.68
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 3.65
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 3.64
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.6
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 3.56
Mutational landscape of splicing genes and functional consequences across 33 cancer types 3.56
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 3.53
Transcriptome landscape of HeLa response upon triamcinolone acetonide 3.48
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.46
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 3.46
Transciptomic profiling of human fetal lung samples 3.44
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.43
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.43
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.43
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 3.41
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 3.41
Polyol pathway links glucose metabolism to the aggressiveness of cancer cells 3.36
BASP1 modifies the Tamoxifen response 3.36
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 3.35
Microprocessor mediates transcription termination in long noncoding microRNA genes 3.31
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 3.3
Functional role of CPPED1 in trophoblasts. 3.27
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 3.27
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 3.26
Expression data from miR340 overexpressing human A549 cells 3.26
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 3.24
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 3.24
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.23
Selective expression of long non-coding RNAs in a breast cancer cell progression model 3.21
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 3.19
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 3.14
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 3.11
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 3.09
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 3.08
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 3.07
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 3.07
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 3.07
Transcriptome wide analysis of translation efficiency in MCF7 cells using polysome profiling with and without eIF4A inhibition by hippuristanol treatment 3.02
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 2.98
Ribosome profiling upon inhibition of eIF4A 2.98
Interaction between mitoNEET and NAF-1 in cancer cells 2.96
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 2.95
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 2.95
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 2.89
Inhibition of the Aryl Hydrocarbon Receptor - Polyamine Biosynthesis Axis Suppresses Multiple Myeloma and prostate cancer progression 2.88
Single-cell ID-seq identifies BMP signaling as a driver of a late stage epidermal differentiation program. 2.83
Effect of BMP inhibition or stimulation of primary human keratinocytes 2.83
PRDM1 inhibits proliferation of human colon cancer organoids 2.74
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.71
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 2.71
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 2.65
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 2.61
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.59
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.58
Disruption of Na+/H+ exchanger regulatory factor 2 scaffold suppresses colon cancer proliferation 2.58
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.58
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.58
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 2.57
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 2.57
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 2.53
Expression profiling of MCF-7 cells with treatment of TCDD 2.5
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 2.5
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 2.49
Proteomics identifies a marker signature of MAPKi resistance in melanoma 2.46
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 2.39
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 2.39
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 2.39
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 2.35
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.34
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 2.32
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 2.31
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.29
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 2.29
RNA-seq of RKO cells with cTAZ KO or putback 2.27
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 2.27
Identification of atheroprone shear stress responsive regulatory elements in endothelial cells 2.26
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 2.23
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.21
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.21
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 2.21
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 2.18
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 2.14
Effect of OVO-like 1 knockdown on global transcript expression in differentiated BeWo trophoblast cells 2.12
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 2.09
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 2.08
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 2.07
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 2.06
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 2.06
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.06
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.06
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 2.02
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 2.02
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 2.01
1.95
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 1.93
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 1.9
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.9
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on HepG2) 1.88
Simultaneous quantification of antibody-RNA conjugates and the transcriptome from fixed cells by RAID 1.87
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 1.87
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.84
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 1.83
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 1.77
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) 1.77
Epigenetic changes induced by Bacteroides fragilis toxin (BFT) [RNA-seq] 1.77
Hsa-miR-139-5p/HNRNPF axis modulates gene-transcripts balance in thyroid cancer cells 1.75
Ribosomal protein RPL26 is the principal target of UFMylation 1.73
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.7
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 1.68
RNA-Seq analysis of HIF-2a-responsive genes in clear-cell renal cell carcinoma 1.68
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 1.67
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.62
Transcriptome profiling of 5 human adenocarcinoma cell lines 1.6
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 1.59
Energy Metabolism during Anchorage-Independence 1.59
ERK signaling regulates opposing functions of JUN family transcription factors in prostate cancer cell migration 1.58
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 1.58
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 1.55
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 1.55
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 1.51
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 1.5
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.49
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.46
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 1.44
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 1.43
The bromodomain protein BRD4 regulates splicing during heat shock 1.37
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.37
Tumor hypoxia causes DNA hypermethylation by reducing TET activity (RNA-Seq) 1.36
Tumor hypoxia causes DNA hypermethylation by reducing TET activity 1.36
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.35
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.35
CRISPR-Cas9 based screen for p53-bound enhancers that function in oncogene-induced senescence 1.35
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 1.32
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.31
HEK293 TFAM Knockout Expression Study 1.26
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.26
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.26
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.21
MALT1 Inhibition Is Efficacious in Both Naïve and Ibrutinib-Resistant Chronic Lymphocytic Leukemia. 1.2
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 1.18
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.13
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 1.1
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.1
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.09
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.06
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 1.01
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.97
The transcriptome effect of overexpressing EZH2 in MCF7 0.95
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.95
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 0.91
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.87
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 0.85
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.82
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 0.79
A cell cycle-based functional screen to identify lncRNA-based cancer biomarkers 0.79
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 0.78
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 0.76
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.76
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.72
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 0.68
Gene expression profile in breast cancer cells 0.68
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 0.66
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 0.66
A comprehensive single cell transcriptional landscape of human hematopoietic progenitors 0.65
Gene expression profiles of PD1-high, PD1-intermediate, and PD1-negative tumor-infiltrating CD8 T cells in hepatocellular carcinoma 0.64
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 0.61
A transcriptome dataset revealing the molecular features of breast cancer stem cells 0.59
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.56
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.52
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.52
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.52
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.51
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.5
m6A-dependent regulation of messenger RNA stability 0.5
miRNAs affected by antagomiR-17 treatment 0.49
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.49
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.48
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.48
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 0.47
Discovering human diabetes-risk gene function with genetics and physiological assays 0.46
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.45
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq1] 0.42
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 0.39
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.38
Alterations of the MEK/ERK, BMP, and Wnt/b-catenin pathways detected in the blood of individuals with lymphatic malformations 0.37
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.34
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.34
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 0.32
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.31
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.31
Fusion discovery in breast cancer cell line 0.31
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 0.3
Single Cell RNASeq profiling of stromal vascular fraction from Subcutaneous and visceral adipose tissue 0.28
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.28
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 0.26
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 0.26
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.25
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.25
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.24
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.24
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.23
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 0.22
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 0.2
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.17
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 0.17
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 0.17
Wnt1 silences CC/CXC motif chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma 0.16
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.16
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 0.14
The role of the Calcium-Sensing receptor in colorectal cancer 0.14
O-glcnAc reprograms cellular energetics 0.12
RUVBL1/RUVBL2 ATPase Activity Drives PAQosome Maturation, DNA Replication and Radioresistance in Lung Cancer 0.11
RNA-sequencing experiment: Treatment of MCF-7 breast cancer cells with the novel small molecule ZNA 0.11
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.11
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 0.11
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 0.11
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 0.05
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.04
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.04
DLX3 alters transcriptomic profile of adhesion, cell cycle, and cell death in Squamous Cell Carcinoma Cells 0.03
DLX3-dependent p53 signaling network controls keratinocyte cell cycle and squamous tumor growth 0.03
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.03
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 0.02
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 0.02
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.02
Function and hormonal regulation of GATA3 in human first trimester placentation 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation